Before joining the University of Pittsburgh, Dr. Burke was a professor at the Johns Hopkins Bloomberg School of Public Health ...
A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...
Almost a year after an appellate court judge revoked its previous permit, Harm Reduction Coalition of Santa Cruz County is ...
Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...
Researchers at the Icahn School of Medicine have unveiled the AMETA Nanobody Platform, which effectively combats SARS-CoV-2 ...
Tennessee Gov. Bill Lee made waves in early 2023, when he rejected millions of dollars in federal HIV prevention programming.
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...
With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...